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Quantitative structure–activity relationship (QSAR) studies on 24 Amaryllidaceae alkaloids, belonging to five ring types, as
acetylcholinesterase inhibitors were carried out using physicochemical properties as descriptors. Multiple linear regression analysis of the data
has shown that strain energy, heat of formation and substituents at both the aromatic ring and ring C play important roles in the development of the
QSAR model. The contribution of substituents at ring C to the model was further supported when strain energy was omitted from the model and
ring-type based QSAR analysis for crinine- and lycorine-type alkaloids were performed.
D 2006 SAAB. Published by Elsevier B.V. All rights reserved.Keywords: Acetylcholinesterase enzyme; Amaryllidaceae; Alkaloids; QSAR1. Introduction
Acetylcholinesterase enzyme (AChE) inhibitors from
general chemical classes such as physostigmine, tacrine and
heptylphysostigmine have been tested for the symptomatic
treatment of Alzheimer’s disease (AD) (Becker and Giaco-
bini, 1988). Clinical studies have shown symptomatic
improvements in some patients resulting in the approval of
these compounds for the treatment of AD. However, non-
selectivity of these drugs, their limited efficacy, poor
bioavailability, adverse cholinergic side effects in the periph-
ery, narrow therapeutic ranges and hepatotoxicity are among
the severe limitations to their therapeutic success (Bores et
al., 1996).
Recently, the Amaryllidaceae alkaloid galanthamine 17 was
approved in many European countries for the treatment of
Alzheimer’s disease (Sramek et al., 2000). The long acting,
selective, reversible, and competitive AChE inhibitory proper-
ties of galanthamine led to the search for other AChE
inhibitors from the family Amaryllidaceae (Sweenly et al.,0254-6299/$ - see front matter D 2006 SAAB. Published by Elsevier B.V. All righ
doi:10.1016/j.sajb.2005.08.001
* Corresponding author.
E-mail address: vanstadenj@ukzn.ac.za (J. van Staden).1989; Thompsen et al., 1990, 1991). The research focussed
mainly on galanthamine-type alkaloids. Significant AChE
inhibitory activity for Amaryllidaceae alkaloids other than
galanthamine-type alkaloids such as the lycorine-type alkaloids
assoanine 14, oxoassoanine 15 and 1-O-acetyllycorine 10 has
also been reported (Lo´pez et al., 2002; Elgorashi et al., 2004).
The higher activity of assoanine and oxoassoanine with respect
to other lycorine-type alkaloids was attributed to the aroma-
tisation of ring C (Fig. 1) which gives a certain planarity to
those alkaloids (Lo´pez et al., 2002). The fact that 1-O-
acetyllycorine 10 lacks aromatisation at ring C and is 200-fold
more potent than lycorine 9, 2-O-acetyllycorine 11 and 1,2-O-
diacetyllycorine 12, prompted the search for other properties
that affect the binding of the ligand to the active site of the
enzyme.
Quantitative structure–activity relationship (QSAR) devel-
opment provides a powerful tool to correlate the biological
activities of compounds to their structural or physicochemical
parameters and extends the correlated parameters for the
prediction of new active ligands (Viswanadhan et al., 1989).
The aim of this study was to uncover the relationship of the
AChE inhibitory effects, expressed as IC50, of Amaryllida-
ceae alkaloids and their physicochemical properties using
stepwise multiple linear regression analysis.ny 72 (2006) 224 – 231
wwts reserved.
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The alkaloids used in this study as a training set were isolated
from a number of Amaryllidaceae species (Fig. 1). Crinine (1),
epibuphanisine (2), epivittatine (3), crinamidine (6), 1-O-
acetyllycorine (10) and Cherylline (20) were isolated from
Crinum moorei (Elgorashi et al., 2001a). 3-O-Acetylhamayne    
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Fig. 1. Chemical structures of Amaryllidaceae alkaloids used for model developmen
crinamidine 6, crinamine 7, 6-hydroxycrinamine 8, lycorine 9, 1-O-acetyllycorin
assoanine 14, oxoassoanine 15, epinorgalanthamine 16, galanthamine 17, san
ethoxyprecriwelline 22, N-desmethyl-8a-ethoxypretazettine 23, N-desmethyl-8h-
numbering of each ring type. It was carried out for illustrative purposes.(5), crinamine (7), 6-hydroxycrinamine (8), 8a-ethoxyprecri-
welline (22), N-desmethyl-8a-ethoxypretazettine (23) and N-
desmethyl-8h-ethoxypretazettine (24) were isolated from C.
bulbispermum (Elgorashi et al., 1999). Hamayne (4) and
lycorine (9) were isolated from C. macowanii (Elgorashi et
al., 2001b). Tazettine (21) was isolated from Cyrtanthus
falcatus (Elgorashi and van Staden, 2003). 2-O-Acetyllycorine      
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acetylation of 9 and galanthamine (17) was obtained from
Sigma-Aldrich. The purity of the above-mentioned alkaloids,
assessed using GC–MS, were found to be >95%. The procedure
used for acetylcholinesterase inhibitory activity of the above-
mentioned alkaloids is detailed elsewhere (Elgorashi et al.,
2004). The IC50 values were determined by regression analysis
and calculated from at least four individual determinations each
performed in duplicate. AChE inhibitory effects of pseudoly-
corine (13), assoanine (14), oxoassoanine (15), epinorgalantha-
mine (16), sanguinine (18) and 11-hydroxygalanthamine (19)
were obtained from literature (Lo´pez et al., 2002) and correlated
to experimental values obtained in our laboratory.
Advanced chemistry development’s ACD/ChemSketch\
program (ACD/ChemSketch\ 4.54, 2000) was used to
calculate molar refractivity (A˚3), molecular volume (cm3),
parachor (A˚3), density (g/cm3), refractive index, surface tension
(dyne/cm) and polarisability (A˚3). ACD/Log P\ (ACD/LogP\
4.54, 2000) was used to calculate lipophilicity (log P),
lipophilicity of the neutral form (log PNF), log D, log D7.4
and degree of ionisation (pKa).
Structural optimization was accomplished using MMFF94
(Merck Molecular Force Field) calculations in the PC Spartan
Pro\ modelling software (PC Spartan Pro\ 1.0, 1999). MM+
and AM1 minimization models were used for molecular and
electronic calculations. Strain energy (E; kcal/mol) was
determined from molecular mechanics calculations and heat
of formation (HF; kcal/mol), solvation energy (kcal/mol) and
electrostatic potential from semi-empirical calculations.Spartan Pro\ 1.0 was further used to calculate the surface
electrostatic potential map from semi-empirical calculations
(AM1) as well for the alignment of the different alkaloids. For
superpositions, 1-O-acetyllycorine and galanthamine mole-
cules in their minimum-energy conformation were used as
references. The compounds are all of similar molecular size
and relatively rigid and hence atoms 1–3 in the aromatic ring
of the reference and the test compound were selected for
superpositioning. Stepwise multiple regression analysis of the
QSAR data was carried out using Statistica (Statistica data
analysis software system\ 6.0, 2003).
3. Results and discussion
The physicochemical properties of the 24 Amaryllidaceae
alkaloids and their AChE inhibitory effects expressed as
IC50 are presented in Table 1. Single linear regression
analysis of the IC50 of AChE inhibitory effects of these
alkaloids and their physico-chemical properties did not
reveal significant correlations between the individual descrip-
tors and the IC50.
Stepwise multiple linear regression analysis of all data
resulted in a five-component model (Eq. (1)). Strain energy
(E), heat of formation (HF), electrostatic potential (EP) at
carbons 3 and 12, and at oxygen 16 were found to be the
major descriptors of the of AChE inhibitory (Log IC50)
effects of these Amaryllidaceae alkaloids. Omission of strain
energy (Eq. (2)) revealed electrostatic potential at carbons 3, 7
and 12 together with oxygen 16 and the heat of formation as
Table 1
Physicochemical properties of the different Amaryllidaceae alkaloids investigated
Alkaloid IC50 (AM) MW MR MV Para RI ST D Pol Log P Log PNR Log D Log D7.4 pKa E HF SE
1 461 271.311 73.64 188.9 544.8 1.707 69.1 1.43 29.19 1.23 1.34 1.65 1.02 14.177 70.68 47.37 14.05
2 547 285.338 78.47 213.8 588.2 1.654 57.2 133 31.11 1.98 2.09 1.61 1.84 7.302 80.05 42.38 11.17
3 239 271.311 73.64 188.9 544.8 1.707 69.1 1.43 29.19 1.23 1.34 0.77 1.02 14.177 67.17 53.34 12.37
4 553 287.311 75.15 186.9 559.7 1.737 80.4 1.53 29.79 0.06 0.17 0.1 0.14 14.551 107.82 94.66 15.08
5 594 329.347 84.74 224.9 648.4 1.677 69.0 1.46 33.59 0.94 1.05 1.01 1.03 14.228 108.78 127.43 14.50
6 300 317.337 79.75 205.9 602.6 1.701 73.2 1.54 31.61 0.61 1.08 0.74 0.91 14.128 96.68 101.96 15.24
7 697 301.337 79.99 211.8 603.1 1.679 65.7 1.42 31.71 0.81 0.92 0.87 0.9 14.278 102.3 88.17 12.70
8 490 317.337 81.5 209.8 618.1 1.704 75.3 1.51 32.31 0.3 0.19 0.19 0.19 14.418 83.68 129.08 15.41
9 213 287.311 74.89 168.9 557.7 1.733 79.1 1.53 29.69 1.02 1.02 0.98 1.00 14.58 97.70 100.26 14.78
10 0.960 329.347 84.48 225.0 646.3 1.674 68.0 1.46 33.49 1.15 1.15 1.14 1.15 13.416 69.29 128.33 13.29
11 169 329.347 84.48 225.0 646.3 1.674 68.0 1.46 33.49 1.45 1.45 1.43 1.44 13.464 89.56 128.09 13.52
12 211 371.384 94.06 262.9 735.0 1.634 77.1 1.41 37.29 2.52 2.52 2.51 2.51 5.211 78.90 154.17 14.51
13 152 289.326 76.73 197.0 583.8 1.706 55.5 1.46 30.41 0.12 0.12 0.11 0.11 14.66 99.05 123.30 14.21
14 3.87 267.322 77.86 211.2 576.8 1.658 61.0 1.26 30.86 3.51 3.51 3.51 3.51 6.673 82.43 5.96 8.18
15 47.2 281.306 77.97 208.2 582.2 1.672 57.9 1.35 30.91 2.88 2.88 2.87 2.87 1.971 70.66 42.25 8.49
16 9.60 273.327 75.45 208.8 576.2 1.642 56.6 1.3 29.91 1.24 1.24 0.51 0.14 13.978 56.88 72.41 11.13
17 1.90 287.354 80.31 223.9 614.3 1.636 67.8 1.28 31.83 1.59 1.59 0.61 0.94 13.981 70.998 64.14 9.08
18 0.100 273.327 75.47 198.9 570.9 1.683 64.6 1.37 29.92 0.78 0.82 0.22 0.11 14.059 54.30 71.52 11.86
19 1.61 303.353 81.82 221.9 629.3 1.658 50.6 1.36 32.43 0.62 0.66 0.31 0.49 14.049 103.65 103.81 11.79
20 407 285.338 81.58 232.3 619.7 1.619 64.0 1.227 32.34 1.77 1.77 0.81 1.14 10.267 71.19 71.53 12.04
21 705 331.363 86.39 233.9 661.9 1.66 53.2 1.41 34.24 1.8 1.54 1.2 1.33 12.116 136.45 122.79 11.66
22 1150 359.416 95.8 275.8 745.0 1.611 53.9 1.3 37.98 2.33 2.07 1.29 1.59 7.107 157.02 67.71 9.66
23 234 345.39 90.94 260.8 706.8 1.614 53.9 1.32 36.05 1.72 1.46 0.32 0.67 7.614 100.22 133.14 10.99
24 419 345.39 90.94 260.8 706.8 1.614 53.9 1.32 36.05 1.72 1.46 0.32 0.67 7.614 100.74 133.92 10.80
Alkaloid (EP)
IC50 (AM) C2 C3 C4 C7 C8 C9 C10 C11 C12 C13 C14 C15 O16 O17 N18
1 461 0.208 0.277 0.321 0.16 0.17 0.162 0.236 0.188 0.181 0.272 0.163 0.121 0.376 0.387 0.614
2 547 0.207 0.279 0.303 0.13 0.256 0.287 0.304 0.261 0.145 0.273 0.151 0.116 0.374 0.381 0.626
3 239 0.2 0.307 0.365 0.206 0.124 0.125 0.198 0.195 0.206 0.219 0.044 0.117 0.379 0.387 0.577
4 553 0.213 0.281 0.305 0.017 0.137 0.122 0.245 0.213 0.123 0.181 0.006 0.107 0.377 0.384 0.571
5 594 0.206 0.281 0.299 0.019 0.092 0.175 0.311 0.192 0.145 0.167 0.045 0.133 0.385 0.393 0.574
6 300 0.268 0.105 0.174 0.26 0.173 0.262 0.207 0.029 0.092 0.286 0.181 0.159 0.372 0.372 0.610
7 697 0.226 0.249 0.273 0.059 0.03 0.051 0.152 0.145 0.165 0.179 0.058 0.063 0.377 0.377 0.543
8 490 0.275 0.213 0.202 0.069 0.011 0.004 0.14 0.153 0.157 0.144 0.055 0.497 0.386 0.376 0.598
9 213 0.231 0.246 0.248 0.056 0.209 0.082 0.332 0.193 0.174 0.175 0.177 0.289 0.384 0.386 0.677
10 0.960 0.25 0.203 0.165 0.568 0.495 0.102 0.143 0.006 0.597 0.171 0.102 0.341 0.389 0.386 0.623
11 169 0.235 0.223 0.176 0.491 0.454 0.14 0.088 0.065 0.342 0.097 0.039 0.269 0.379 0.389 0.589
12 211 0.259 0.22 0.162 0.325 0.297 0.123 0.12 0.165 0.296 0.136 0.081 0.294 0.385 0.385 0.568
13 152 0.214 0.173 0.159 0.102 0.221 0.102 0.356 0.231 0.168 0.23 0.237 0.368 0.453 0.339 0.689
14 3.87 0.187 0.159 0.125 0.219 0.295 0.018 0.134 0.158 0.037 0.182 0.199 0.409 0.368 0.363 0.630
15 47.2 0.269 0.126 0.065 0.077 0.1 0.017 0.145 0.102 0.104 0.166 0.028 0.729 0.360 0.282 0.331
16 9.60 0.232 0.188 0.136 0.379 0.241 0.209 0.248 0.157 0.007 0.196 0.249 0.21 0.346 0.306 0.799
17 1.90 0.205 0.183 0.177 0.31 0.252 0.214 0.273 0.172 0.065 0.165 0.243 0.041 0.337 0.330 0.564
18 0.100 0.227 0.167 0.188 0.21 0.172 0.264 0.314 0.188 0.175 0.223 0.255 0.063 0.480 0.376 0.591
19 1.61 0.187 0.235 0.043 0.132 0.054 0.247 0.287 0.164 0.227 0.154 0.177 0.110 0.340 0.392 0.408
20 407 0.183 0.189 0.157 0.294 0.06 0.017 0.295 0.365 0.251 0.105 0.321 0.318 0.335 0.451 0.646
21 705 0.268 0.231 0.230 0.182 0.295 0.205 0.333 0.250 0.142 0.301 0.192 0.247 0.392 0.382 0.690
22 1150 0.271 0.238 0.208 0.009 0.393 0.177 0.338 0.431 0.018 0.258 0.016 0.610 0.386 0.385 0.723
23 234 0.257 0.255 0.237 0.096 0.266 0.232 0.403 0.357 0.016 0.290 0.001 0.575 0.396 0.401 0.816
24 419 0.261 0.259 0.224 0.087 0.243 0.182 0.352 0.287 0.003 0.273 0.117 0.689 0.383 0.386 0.805
MW=Molecular weight, MR=Molar refractivity, MV=Molar volume, Para=Parachor, RI=Refractive index, ST=Surface tension, D =Density, Pol=Polarizability,
Log P=Lipophilicity, Log PNF=Lipophilicity of the neutral form, pKa=Degree of ionisation, E =Strain energy, HF=Heat of formation, SE=Solvation energy.
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alkaloids.
log IC50 ¼ 1:92þ 3:7 EP C3ð Þ  2:46 EP C12ð Þ  0:008 HF
þ 0:009 E þ 5:67 EP O1ð Þ
 n ¼ 24;R2 ¼ 0:87; p < 0:00000  ð1Þlog IC50 ¼ 2:98þ 4:5 EP C3ð Þ  2:13 EP C12ð Þ
 0:009 HFþ 6:91 EP O1ð Þ
þ 0:67 EP C7ð Þ n ¼ 24; R2 ¼ 0:85; p < 0:00000
 
ð2Þ
Fig. 2. Surface electrostatic potential map of: (A) 1-O-acetyllycorine; (B) 2-O-
acetyllycorine; (C) 1, 2-O-diacetyllycorine; (D) galanthamine; (E) sanguinine;
(F) epinorgalanthamine; (G) crinine; (H) maritidine (included for comparison,
did not show AChE inhibitory activity). Red indicates negative charges, blue
represents positive charges. (For interpretation of the references to colour in this
figure legend, the reader is referred to the web version of this article.)
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correlation of Log IC50 with the other physicochemical
properties (R2=0.85). The effect of an energy descriptor such
as the strain energy on the linearity of the model could be
attributed to the importance of conformational requirements for
binding of these molecules to the active site of the enzyme (Zah
et al., 2003).
The electrostatic potential of atoms in ring C (Fig. 1) and the
aromatic ring (ring A) contributed strongly to the linearity of
the model. Atomic charge is a good measure of the electrostatic
forces which govern the interaction of the ligand at a specific
region of the enzyme (Ghose and Crippen, 1987). This effect of
electrostatic potential on these atoms also emphasizes the
importance of substituents on both ring C and the aromatic ring
(ring A).
Amaryllidaceae alkaloids are classified into different ring-
types such as crinine-, lycorine-, galanthamine-, cherylline- and
tazettine-type alkaloids. Including ring type-based regression
analysis further supports the effects of substituents on the
activity. Electrostatic potential on C7 and log D were the prime
descriptors of the Log IC50 of crinine-type alkaloids irrespec-
tive of inclusion or omission of energy (Eq. (3), compound 1–
8) while that on C2 and energy were the important predictors of
lycorine-type alkaloids (Eq. (4), compound 9–15). Omission
of energy indicated that C7 and molar refractivity (MR) were
the main predictors of Log IC50 (Eq. (5)). In both cases an
increase in electron density leads to an increase in activity (Eqs.
(3) and (4)).
log IC50 ¼ 2:78 1:6 EP C7ð Þ
þ 0:085 log D n ¼ 8; R2 ¼ 0:79; p < 0:018 
ð3Þ
log IC50 ¼  11:005þ 0:08 E
þ 24:85 EP C2ð Þ n ¼ 7; R2 ¼ 0:77; p < 0:052
 
ð4Þ
log IC50 ¼ 6:78þ 3:44 EP C7ð Þ
 0:059 MR n ¼ 7; R2 ¼ 0:84; p < 0:025 
ð5Þ
The regression analyses showed that log D has a relatively
small effect on the linear regression power of Log IC50 of
lycorine-type alkaloids and their physicochemical properties.
Log D, the effective partition coefficient for dissociative
systems, is closely related to log P which is the octanol–water
distribution coefficient for neutral species. Almost all of the
alkaloids have positive log P values and therefore are relatively
hydrophobic (Table 1). Hydrogen bonding appears to play a
small role in the binding of these alkaloids to the active site of
the enzyme. This is in line with literature reports where only
two classical hydrogen bonds appear to be formed when the X-
ray crystal structure of galanthamine 17, bound in the activesite of Torpedo californica acetylcholinesterase (TcAChE), was
examined. These hydrogen bonds are between the hydroxyl
group of the inhibitor and the oxygen of the methoxy group of
the protein. The rest of the interactions involve either non-
classical hydrogen bonding, between the N-methyl group of the
inhibitor and the protein, or non-polar interactions (Greenblatt
et al., 1999).
The molar refractivity contributed positively to the linearity
of lycorine-type alkaloid model when the strain energy was
omitted (Eq. (5)) and an increase in molar refractivity is
accompanied by a decrease in log IC50 within this range. This
is not surprising as molar refractivity is one of the parameters
related to the shape and size of the drug necessary for the
effective binding to its target site (Thomas, 2000). Above a
certain critical point, the ligand becomes too bulky to fit into
the active site.
The surface electrostatic potential was calculated to inves-
tigate the correlation between the surface charge distribution
E.E. Elgorashi et al. / South African Journal of Botany 72 (2006) 224–231 229of the alkaloids and their IC50 values. Interestingly, the
surface charge distribution of the most active group of the
Amaryllidaceae alkaloids, namely galanthamine 17, sangui-
nine 18 and epinorgalanthamine 19 were found to be similar
(Fig. 2). The surface electrostatic potential of 1-O-acetylly-
corine 10, the second most active alkaloid in the whole
group, is also much closer to that of the galanthamine-type
alkaloids than to those of the related lycorine-type alkaloids
such as 2-O-acetyllycorine 11 and 1,2-O-diacetyllycorine 12.
These differences in surface charge distribution within the
lycorine-type alkaloids further highlight the effect of
substituents on the activity of a particular alkaloid within
the group.
Superpositioning of galanthamine 17 on 1-O-acetyllycorine
10 (Fig. 3B) indicated that the 1-O-acetyl group and theFig. 3. Superpositioning of: (A) 1-O-acetyllycorine and maritidine (B) 1-O-acetylly
O-acetyllycorine and crinine (E) 1-O-acetyllycorine and cherylline (F) 1-O-acetylly
mine. C = gray, O = red, N = blue, H = white. (For interpretation of the references
article.)nitrogen atom of the later superimpose on the hydroxyl group
and the nitrogen atom of galanthamine, respectively. This
superpositioning confirms the possibility of the hydrogen
bonding capacity of 1-O-acetyllycorine. The log P values of
almost all of the compounds are comparable to that of
galanthamine and hence sufficient to enable them to cross the
blood–brain barrier.
It was also reported that the double bond of the
cyclohexene ring of galanthamine 17 stacks against the
indole–ring binding site while the O-methyl group of
galanthamine occupies the acetyl-binding pocket of acetyl-
choline (Greenblatt et al., 1999). Again, from the analysis and
superpositioning of 1-O-acetyllycorine 10 and other related
lycorine-type alkaloids on galanthamine (Table 2), it appears
that the methoxy group of galanthamine partially aligns withcorine and galanthamine. (C) 1-O-acetyllycorine and 2-O-acetyllycorine (D) 1-
corine and 8a-ethoxyprecriwelline (G) galanthamine and 11-hydroxygalantha-
to colour in this figure legend, the reader is referred to the web version of this
Table 2
Atoms-based description of the molecular superpositionsa
Compounds Atom numbers
1-O-Acetyllycorine/
maritidine
1/1, 2/2, 3/3, 4/4, 5/5, 6/6, 7/7, 8/– , 9/–b, 10/– ,
11/– , 12/– , 13/– , 14/– , 15/15, 16/0, 17/0,
18/18
1-O-Acetyllycorine/
galanthamine
1/1, 2/2, 3/3, 4/4, 5/5, 6/6, 7/7, 8/– , 9/– , 10/– ,
11/– , 12/– , 13/– , 14/– , 15/15, 16/16, 17/– ,
18/18, 11-OH/– , 12-OAc/–
1-O-Acetyllycorine/
2-O-Acetyllycorine
1/1, 2/2, 3/3, 4/4, 5/5, 6/6, 7/7, 8/8, 9/9, 10/10,
11/11, 12/12, 13/13, 14/14, 15/15, 16/16, 17/17,
18/18, 12-OAc/12OAc, 11-OH/11-OCOMe
1-O-Acetyllycorine/
crinine
1/1, 2/2, 3/3, 4/4, 5/5, 6/6, 7/7, 8/– , 9/– , 10/– ,
11/– , 12/– , 13/– , 14/– , 15/15, 16/16, 17/17,
18/18
1-O-Acetyllycorine/
cherylline
1/1, 2/2, 3/3, 4/4, 5/5, 6/6, 7/7, 8/8, 9/– , 10/– ,
11/– , 12/– , 13/– , 14/– , 15/– , 16/16, 17/0,
18/18
1-O-Acetyllycorine/
8a-ethoxyprecriwelline
1/1, 2/2, 3/3, 4/4, 5/5, 6/6, 7/7, 8/8, 9/– , 10/–
Galanthamine/
11-hydroxygalanthamine
1/1, 2/2, 3/3, 4/4, 5/5, 6/6, 7/7, 8/8, 9/9, 10/10,
11/11, 12/12, 13/13, 14/14, 15/15, 16/16, 17/17,
18/18, 10-OH/10-OH, 2-OMe/2-OMe, – /13-OH
1-O-acetyllycorine and galanthamine are used as reference compounds. The
superpositioning atoms are given in the form X/Y, where X is the atom of the
reference and Y is the corresponding superposed atom of the test alkaloid. bNo
corresponding superposed atom of the test alkaloid. All RMS values were <1
indicating favourable fit on the selected compound.
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while the double bond of the cyclohexene ring of galantha-
mine does not align with any part of the lycorine-type
alkaloids. This indicates that the mechanism of binding of 1-
O-acetyllycorine to AChE enzyme might not be the same as
that of galanthamine.
4. Conclusions
The regression analysis based on the physicochemical
properties of all the alkaloids (Eqs. (1) and (2)) shows that
strain energy, heat of formation, and substituents at ring C
and the aromatic ring play significant roles in the activity
against AChE. Good linear regression was obtained when
ring-type based models were established for crinine-type (Eq.
(3), R2=0.79) and lycorine-type (Eqs. (4) and (5), R2=0.77
and 0.84) alkaloids. The latter models also supported the
effect of electrostatic potential on the aromatic ring and ring
C and hence the effect of substituents on these rings. It should
be noted, however, that for these models (Eqs. (3)–(5)) a
smaller number of alkaloids (n =7 and 8) was used. The study
also revealed that log P of most of the alkaloids investigated
is comparable to that of galanthamine and this would
probably facilitate their passage through the brain–blood
barrier.
Alignment of representative alkaloids with galanthamine
revealed that the active binding site of 1-O-acetyllycorine
might be different from that of galanthamine. However, the
surface energy potential showed close similarities in charge
distribution between 1-O-acetyllycorine and galanthamine-type
alkaloids.The predictive potential of the models established in this
study is however limited to this class of compounds and the
physicochemical parameters investigated.
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